Logo image of C1V.DE

MVISE AG (C1V.DE) Stock Fundamental Analysis

FRA:C1V - Deutsche Boerse Ag - DE0006204589 - Common Stock - Currency: EUR

0.59  +0.03 (+5.36%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to C1V. C1V was compared to 69 industry peers in the IT Services industry. C1V has a bad profitability rating. Also its financial health evaluation is rather negative. C1V has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year C1V has reported negative net income.
In the past year C1V had a positive cash flow from operations.
C1V had negative earnings in each of the past 5 years.
C1V had a positive operating cash flow in 4 of the past 5 years.
C1V.DE Yearly Net Income VS EBIT VS OCF VS FCFC1V.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

With a Return On Assets value of -29.91%, C1V is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
C1V has a Return On Equity of -68.51%. This is amonst the worse of the industry: C1V underperforms 85.51% of its industry peers.
Industry RankSector Rank
ROA -29.91%
ROE -68.51%
ROIC N/A
ROA(3y)-28.03%
ROA(5y)-23.65%
ROE(3y)-8196.82%
ROE(5y)-4972.61%
ROIC(3y)N/A
ROIC(5y)N/A
C1V.DE Yearly ROA, ROE, ROICC1V.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

1.3 Margins

With a Gross Margin value of 63.94%, C1V perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
C1V's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for C1V so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.56%
C1V.DE Yearly Profit, Operating, Gross MarginsC1V.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50

More info and screens

2

2. Health

2.1 Basic Checks

C1V does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for C1V has been increased compared to 1 year ago.
Compared to 5 years ago, C1V has more shares outstanding
C1V has a better debt/assets ratio than last year.
C1V.DE Yearly Shares OutstandingC1V.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
C1V.DE Yearly Total Debt VS Total AssetsC1V.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

C1V has an Altman-Z score of -0.42. This is a bad value and indicates that C1V is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of C1V (-0.42) is worse than 82.61% of its industry peers.
C1V has a debt to FCF ratio of 222.79. This is a negative value and a sign of low solvency as C1V would need 222.79 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 222.79, C1V is doing worse than 73.91% of the companies in the same industry.
C1V has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
C1V's Debt to Equity ratio of 1.07 is on the low side compared to the rest of the industry. C1V is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 222.79
Altman-Z -0.42
ROIC/WACCN/A
WACC6.29%
C1V.DE Yearly LT Debt VS Equity VS FCFC1V.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 1.17 indicates that C1V should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.17, C1V is in line with its industry, outperforming 46.38% of the companies in the same industry.
A Quick Ratio of 1.17 indicates that C1V should not have too much problems paying its short term obligations.
C1V has a Quick ratio (1.17) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
C1V.DE Yearly Current Assets VS Current LiabilitesC1V.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.91% over the past year.
Looking at the last year, C1V shows a very negative growth in Revenue. The Revenue has decreased by -33.87% in the last year.
Measured over the past years, C1V shows a very negative growth in Revenue. The Revenue has been decreasing by -15.40% on average per year.
EPS 1Y (TTM)26.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.76%
Revenue 1Y (TTM)-33.87%
Revenue growth 3Y-14.47%
Revenue growth 5Y-15.4%
Sales Q2Q%-25.88%

3.2 Future

C1V is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.32% yearly.
Based on estimates for the next years, C1V will show a small growth in Revenue. The Revenue will grow by 7.62% on average per year.
EPS Next Y100%
EPS Next 2Y54.11%
EPS Next 3Y40.78%
EPS Next 5Y28.32%
Revenue Next Year6.19%
Revenue Next 2Y6.97%
Revenue Next 3Y9.52%
Revenue Next 5Y7.62%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
C1V.DE Yearly Revenue VS EstimatesC1V.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5M 10M 15M 20M
C1V.DE Yearly EPS VS EstimatesC1V.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2028 2029 2030 2031 0 0.1 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for C1V. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
C1V.DE Price Earnings VS Forward Price EarningsC1V.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

72.46% of the companies in the same industry are cheaper than C1V, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, C1V is valued a bit more expensive than the industry average as 73.91% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 448.4
EV/EBITDA 165.71
C1V.DE Per share dataC1V.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as C1V's earnings are expected to grow with 40.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.11%
EPS Next 3Y40.78%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for C1V!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MVISE AG

FRA:C1V (5/9/2025, 7:00:00 PM)

0.59

+0.03 (+5.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-28 2025-04-28
Earnings (Next)08-04 2025-08-04
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.77%
Ins Owner ChangeN/A
Market Cap12.56M
Analysts80
Price Target1.33 (125.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.35
P/FCF 448.4
P/OCF 448.4
P/B 2.16
P/tB N/A
EV/EBITDA 165.71
EPS(TTM)-0.26
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0
FCFY0.22%
OCF(TTM)0
OCFY0.22%
SpS0.44
BVpS0.27
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.91%
ROE -68.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.94%
FCFM 0.3%
ROA(3y)-28.03%
ROA(5y)-23.65%
ROE(3y)-8196.82%
ROE(5y)-4972.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.56%
F-Score5
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 222.79
Debt/EBITDA 58.3
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 26.17%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z -0.42
F-Score5
WACC6.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.76%
EPS Next Y100%
EPS Next 2Y54.11%
EPS Next 3Y40.78%
EPS Next 5Y28.32%
Revenue 1Y (TTM)-33.87%
Revenue growth 3Y-14.47%
Revenue growth 5Y-15.4%
Sales Q2Q%-25.88%
Revenue Next Year6.19%
Revenue Next 2Y6.97%
Revenue Next 3Y9.52%
Revenue Next 5Y7.62%
EBIT growth 1Y7.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year206.67%
EBIT Next 3Y57.35%
EBIT Next 5Y34.29%
FCF growth 1Y-91.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.18%
OCF growth 3YN/A
OCF growth 5Y-55.7%